211 related articles for article (PubMed ID: 17593991)
41. Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol.
Nodari S; Metra M; Dei Cas L
Eur J Heart Fail; 2003 Oct; 5(5):621-7. PubMed ID: 14607201
[TBL] [Abstract][Full Text] [Related]
42. The antihypertensive and cardiac hemodynamic effects of nebivolol.
DeCrée J; Van Rooy P; Geukens H; Haeverans K; Verhaegen H
Angiology; 1992 May; 43(5):369-77. PubMed ID: 1348916
[TBL] [Abstract][Full Text] [Related]
43. Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension.
Pronko TP; Zinchuk VV
Clin Physiol Funct Imaging; 2009 May; 29(3):170-6. PubMed ID: 19170724
[TBL] [Abstract][Full Text] [Related]
44. [Short-term effect of nebivolol on the left ventricular diastolic function].
Demiralp E; Kardeşoğlu E; Celik T; Cebeci BS; Ozmen N; Işilak Z; Ulusoy RE; Dinçtürk M
Anadolu Kardiyol Derg; 2004 Dec; 4(4):323-36. PubMed ID: 15590361
[TBL] [Abstract][Full Text] [Related]
45. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.
Brixius K; Middeke M; Lichtenthal A; Jahn E; Schwinger RH
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):327-31. PubMed ID: 17324145
[TBL] [Abstract][Full Text] [Related]
46. Aortic elastic properties : effects of carvedilol versus nebivolol.
Sayin MR; Aydin M; Dogan SM; Karabag T; Cetiner MA; Aktop Z
Herz; 2013 May; 38(3):299-305. PubMed ID: 23263241
[TBL] [Abstract][Full Text] [Related]
47. Assessment of effect of irbesartan and nebivolol on the left atrium volume and deformation in the patients with mild-moderate hypertension.
Degirmenci H; Duman H; Demirelli S; Bakirci EM; Hamur H; Inci S; Simsek Z; Askın L; Arısoy A; Lazoglu Z
Eur Rev Med Pharmacol Sci; 2014; 18(6):781-9. PubMed ID: 24706300
[TBL] [Abstract][Full Text] [Related]
48. Quality of life and efficacy of nebivolol in an open-label study in hypertensive patients. the QoLaN study.
Hermans MP; De Coster O; Seidel L; Albert A; Van de Borne P
Blood Press Suppl; 2009 Oct; 1():5-14. PubMed ID: 20050100
[TBL] [Abstract][Full Text] [Related]
49. In vivo and in vitro effects of nebivolol on penile structures in hypertensive rats.
Toblli JE; Cao G; Casas G; Mazza ON
Am J Hypertens; 2006 Dec; 19(12):1226-32. PubMed ID: 17161767
[TBL] [Abstract][Full Text] [Related]
50. A review of the safety and efficacy of nebivolol in the mildly hypertensive patient.
Cockcroft J
Vasc Health Risk Manag; 2007; 3(6):909-17. PubMed ID: 18200810
[TBL] [Abstract][Full Text] [Related]
51. Comparative effects of nebivolol and metoprolol on red cell distribution width and neutrophil/lymphocyte ratio in patients with newly diagnosed essential hypertension.
Fici F; Celik T; Balta S; Iyisoy A; Unlu M; Demitkol S; Yaman H; Brambilla G; Kardesoglu E; Kilic S; Yokusoglu M; Grassi G
J Cardiovasc Pharmacol; 2013 Oct; 62(4):388-93. PubMed ID: 23921307
[TBL] [Abstract][Full Text] [Related]
52. Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients.
Celik T; Iyisoy A; Kursaklioglu H; Kardesoglu E; Kilic S; Turhan H; Yilmaz MI; Ozcan O; Yaman H; Isik E; Fici F
J Hypertens; 2006 Mar; 24(3):591-6. PubMed ID: 16467663
[TBL] [Abstract][Full Text] [Related]
53. Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension.
Tuncer M; Guntekin U; Gunes Y; Gumrukcuoglu HA; Eryonucu B
Adv Ther; 2008 Jun; 25(6):619-26. PubMed ID: 18563311
[TBL] [Abstract][Full Text] [Related]
54. [Dynamics of a 24-h profile of arterial pressure and function of the vascular endothelium in nebivolol treatment of hypertensive patients].
Gel'tser BI; Kotel'nikov VN
Klin Med (Mosk); 2003; 81(8):53-6. PubMed ID: 14520947
[TBL] [Abstract][Full Text] [Related]
55. Left ventricular mass and mechanics in mild-to-moderate hypertension: effect of nebivolol versus telmisartan.
Fountoulaki K; Dimopoulos V; Giannakoulis J; Zintzaras E; Triposkiadis F
Am J Hypertens; 2005 Feb; 18(2 Pt 1):171-7. PubMed ID: 15752943
[TBL] [Abstract][Full Text] [Related]
56. Vascular effects of nebivolol added to hydrochlorothiazide in African Americans with hypertension and echocardiographic evidence of diastolic dysfunction: the NASAA study.
Khan BV; Rahman ST; Haque T; Merchant N; Bhaheetharan S; Harris J; Umar K; Wahi J; Ferdinand KC
J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):291-7. PubMed ID: 22388001
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and tolerability of nebivolol compared with other antihypertensive drugs: a meta-analysis.
Van Bortel LM; Fici F; Mascagni F
Am J Cardiovasc Drugs; 2008; 8(1):35-44. PubMed ID: 18303936
[TBL] [Abstract][Full Text] [Related]
58. Effects of nebivolol and atenolol on small arteries and microcirculatory endothelium-dependent dilation in hypertensive patients undergoing isometric stress.
Arosio E; De Marchi S; Prior M; Zannoni M; Lechi A
J Hypertens; 2002 Sep; 20(9):1793-7. PubMed ID: 12195121
[TBL] [Abstract][Full Text] [Related]
59. Comparison between nebivolol and ramipril in patients with hypertension and left ventricular hypertrophy: a randomized open blinded end-point (PROBE) trial.
Cağlar N; Dincer I
Eur Rev Med Pharmacol Sci; 2011 Dec; 15(12):1359-68. PubMed ID: 22288296
[TBL] [Abstract][Full Text] [Related]
60. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
Giles TD; Weber MA; Basile J; Gradman AH; Bharucha DB; Chen W; Pattathil M;
Lancet; 2014 May; 383(9932):1889-98. PubMed ID: 24881993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
